Diasorin
DiaSorin Ireland (formerly Biotrin International) has a history of developing niche Immuno Assays, some of which became best-in-class worldwide from both a quality and commercial standpoint.
DiaSorin Ireland's core competencies lie in Product Development, Regulatory compliance, high quality and reliable Manufacturing. These skills are currently being applied to Molecular Diagnostic Product Development and Manufacturing.
Financial Data
-
31st Dec 17 Source: CRO
- €18.7 million turnover
-
-€4.6 million
profit - 69 employees
-
31st Dec 16 Source: CRO
- €19 million turnover
-
€3.5 million
profit - 73 employees
- 2 more years available »
Ranking
By Turnover
(€18.7 million)- 892nd in Top Companies
- 97th in Health
By Employees
(69)- 784th in Top Companies
- 91st in Health
- 69
- €18.7 million
Employees
- John Eskdale Country Manager
Latest News
- 5:33pm Approval given for €31m floating wind project off the Mayo coast
- 3:55pm Fitzgerald buys Bruxelles as homeowners say bye to negative equity
- 3:55pm What the papers say: Fitzgerald buys Bruxelles and an end to negative equity
- Mar 23 Ecocem prepares to pay dividends of up to €5m
- Mar 23 Eir sued by Dutch provider of ‘DIY’ customer care service